Shuttle Pharmaceuticals Competitors and Similar CompaniesClear all

Halozyme Therapeutics's competitors and similar companies include Deciphera Pharmaceuticals and Elevar Therapeutics.

	Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	Elevar Therapeutics Elevar Therapeutics (previously known as LSK BioPharma) is a pharmaceutical company.
Founding Date	Founding Date 1998	Founding Date 2003	Founding Date 2005
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations San Diego, US HQ	Locations Waltham, US HQ Lawrence, US	Locations South San Francisco, US HQ Dublin, IE Salt Lake City, US
Employees	Employees 373157% increase	Employees 35037% increase	Employees 565% decrease
Valuation ($)	Valuation ($) 6.4 b	Valuation ($) 2.2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $1.4b (FY, 2025)	Revenue (est.) $163.4m (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods $228.8m (FY, 2025)	Cost of goods $3.7m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit $1.2b (FY, 2025)	Gross profit $159.6m (FY, 2023)	Gross profit N/A
Net income	Net income $316.9m (FY, 2025)	Net income ($194.9m) (FY, 2023)	Net income N/A
Operating ⚠
Patent Applications	Patent Applications 50 (FY, 2020)	Patent Applications 49 (Aug, 2017)	Patent Applications N/A
Patents (US)	Patents (US) 43 (FY, 2020)	Patents (US) 11 (Aug, 2017)	Patents (US) N/A
Funding
Total funding raised	Total funding raised $ 171.9m	Total funding raised $ 714m	Total funding raised $ 20m